Stocks and Investing
by (remove) : Mohit Bansal
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Mohit Bansal
RSSJSONXMLCSV
Tue, September 17, 2024
Wed, August 7, 2024
Fri, August 2, 2024
Fri, July 26, 2024
Thu, June 27, 2024
Mon, June 24, 2024
Thu, April 25, 2024
Thu, April 18, 2024
Fri, February 16, 2024
Wed, February 14, 2024
Tue, February 6, 2024
Mon, February 5, 2024
Tue, January 2, 2024
Thu, November 9, 2023
Fri, September 22, 2023
Mon, August 7, 2023
Wed, August 2, 2023
Fri, July 28, 2023
Tue, May 2, 2023
Fri, April 28, 2023
Mon, March 13, 2023
Wed, February 1, 2023
Tue, January 3, 2023
Mon, November 28, 2022
Fri, October 28, 2022
Wed, September 28, 2022
Tue, May 17, 2022
Fri, May 6, 2022

Mohit Bansal Maintained (BMRN) at Buy with Decreased Target to $90 on, Sep 17th, 2024


Published on 2024-10-28 14:19:18 - WOPRAI, Mohit Bansal
  Print publication without navigation


Mohit Bansal of Wells Fargo, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $115 to $90 on, Sep 17th, 2024.

Mohit has made no other calls on BMRN in the last 4 months.



There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with Mohit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
  • Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024


These are the ratings of the 6 analyists that currently disagree with Mohit


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
  • Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
  • Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
Contributing Sources